Allergic rhinitis decisions — 2025

The Board granted service connection for lower back pain, claimed as a back condition, and the claim for allergic rhinitis, claimed as a sinus condition from August 10, 2022, was granted on a presumptive basis. The claim for allergic rhinitis prior to August 10, 2022, is remanded.

The Board denied the Veteran's claim for an initial compensable rating for allergic rhinitis as the evidence did not show sufficient obstruction of nasal passages to warrant a compensable evaluation.

The Board granted service connection for rhinitis and awarded attorney fees, but denied service connection for a cervical strain, melanoma, and an increased evaluation of bruxism.

The Board granted a 30 percent disability rating for GERD, but denied service connection for right knee pain, shortness of breath, and sleep apnea.

All appeals for ratings in excess of the current ratings or service connection were dismissed due to impermissible concurrent elections.

The Board denied the Veteran's claims for increased ratings for sinusitis and rhinitis, finding that the evidence did not support a higher rating at any time during the appeal period.

The Board denied the Veteran's claims for increased ratings for allergic rhinitis, sinusitis, and hypertension as there was no evidence of a greater than 50% obstruction of the nasal passage on both sides or complete obstruction on one side for allergic rhinitis; no incapacitating episodes per year requiring prolonged antibiotic treatment or non-incapacitating episodes per year of sinusitis characterized by headaches, pain, and purulent discharge or crusting for sinusitis; and no diastolic pressure predominantly 100 or more or systolic pressure predominantly 200 or more for hypertension.

The Board granted a 20 percent rating for left lower extremity femoral nerve radiculopathy, denied an increased rating in excess of 10 percent for right lower extremity sciatic nerve radiculopathy, and restored the 40 percent rating for left lower extremity sciatic, musculocutaneous, and external cutaneous nerve radiculopathy. The Board also remanded claims for service connection.

The Board granted service connection for allergic rhinitis, resolving reasonable doubt in the Veteran's favor.

The Board granted an earlier effective date of April 14, 2022, for the award of service connection for rhinitis but denied a compensable evaluation.

The Board denied the veteran's claims for increased ratings for various service-connected conditions, finding that the evidence did not support higher disability ratings under applicable criteria.

The Board denied the Veteran's claims for increased ratings and compensable ratings for chronic bronchitis, allergic rhinitis, and chronic sinusitis based on the evidence of record.

The Board denied the veteran's claims for increased ratings and remanded the claims for service connection for carpal tunnel syndrome.

The Board granted service connection for a psychiatric disability, currently diagnosed as mood disorder with anxiety, and denied service connection for acne and acne scars, sinusitis, headaches, gastroesophageal reflux disease (GERD), and allergic rhinitis.

The Board dismissed the claims for service connection for lung condition, allergic rhinitis, and sinus condition as they were granted in a previous rating decision.

The Board remands the issues of service connection for sinusitis and rhinitis, GERD, and anxiety and depression due to exposure to toxins during service.

The Board denied service connection for tinnitus, remanded the claims for rhinitis, sinusitis, and obstructive sleep apnea.

The Board denied the Veteran's claim for service connection for a kidney disease, finding no evidence linking his current condition to his military service or exposure to contaminated water at Camp Lejeune. The claims for obstructive sleep apnea, upper respiratory disability, and idiopathic thrombocytopenic purpura were remanded for further development.

The Board granted service connection for chronic allergic rhinitis, chronic headaches, and OSA on a presumptive basis due to toxic exposure while stationed in the Persian Gulf. The claims for atherosclerosis, chronic headaches, and OSA were remanded for further development.

The Board remands the issue of entitlement to an initial compensable rating for allergic rhinitis due to the need for additional evidentiary development, specifically imaging studies to assess the severity of the condition.